John Stoves
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
John Stoves has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Alexander M Davison
Department of Renal Medicine, St James's University Hospital, Leeds, West Yorkshire, UK
1 shared publicationC G Newstead
Department of Renal Medicine, St James's University Hospital , Beckett Street, Leeds LS9 7TF, UK
1 shared publicationC N Bartlett
Department of Renal Medicine, St James's University Hospital , Beckett Street, Leeds LS9 7TF, UK
1 shared publicationCharles G Newstead
Department of Renal Medicine, St James's University Hospital, Leeds, West Yorkshire, UK
1 shared publicationEric J Will
Department of Renal Medicine, St James's University Hospital, Leeds, West Yorkshire, UK
1 shared publication
Latest Publications
- 1 February 2002
- Published by Wiley in Nephrology
- Vol. 7 (1) , 29-32
Elective withdrawal of cyclosporin following renal transplantation: A single centre experience
- 1 February 2002
- Published by Wiley in Nephrology
- Vol. 7 (1) , 29-32
Elective withdrawal of cyclosporin following renal transplantation: A single centre experience
- Open Access
- 1 September 2001
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 77 (911) , 586-588
Specialist follow up of patients before end stage renal failure and its relationship to survival on dialysis
The high mortality rate of patients with end stage renal failure (ESRF) treated by dialysis is determined principally by irreversible factors such as age and comorbidity. In this single centre retrospective study of all 1260 ESRF patients who started dialysis between 1980 and 1999 it has been demonstrated that a short duration of specialist predialysis follow up is associated with a worse long term outcome on dialysis. Kaplan-Meier survival curves were plotted according to duration of predialysis follow up (group A, ⩽ 90 days; group B >90 days), censoring for first transplant, and compared using a log rank test. Differences between groups were examined using an unpaired t test. Cox regression analysis was performed to examine the influence of selected variables on survival. Group A had the worst mortality (survival proportions of 87%, 74%, and 31% in A and 94%, 87%, and 55% in B at four months, one year, and five years respectively, p<0.001). The increased risk of death was seen principally during the first few months of dialysis. ESRF associated with systemic disease was more prevalent in A. There were small but significant differences in predialysis clinical data, including age and serum albumin (p<0.001). Fewer patients in A were suitable for transplant listing (p<0.01). In the regression analysis, age, diabetes, predialysis serum albumin, suitability for transplant work-up and listing (“transplantability”), and the interval between referral and dialysis were significant predictors of survival. In summary, this study strengthens the previously reported association between late referral of ESRF patients and subsequent poor survival on dialysis. This important message is relevant to all potential referring physicians. The high mortality rate of patients with ESRF treated by dialysis is determined principally by irreversible factors such as age and comorbidity. We have demonstrated in a single centre retrospective study of more than 1200 patients with ESRF that a short duration of specialist predialysis follow up is associated with an increased risk of death on dialysis, principally during the first few months of treatment. Delays in the referral to renal specialist services of patients with advanced chronic renal failure should be minimised.
- 1 September 2001
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 77 (911) , 586-588
Open AccessSpecialist follow up of patients before end stage renal failure and its relationship to survival on dialysis
The high mortality rate of patients with end stage renal failure (ESRF) treated by dialysis is determined principally by irreversible factors such as age and comorbidity. In this single centre retrospective study of all 1260 ESRF patients who started dialysis between 1980 and 1999 it has been demonstrated that a short duration of specialist predialysis follow up is associated with a worse long term outcome on dialysis. Kaplan-Meier survival curves were plotted according to duration of predialysis follow up (group A, ⩽ 90 days; group B >90 days), censoring for first transplant, and compared using a log rank test. Differences between groups were examined using an unpaired t test. Cox regression analysis was performed to examine the influence of selected variables on survival. Group A had the worst mortality (survival proportions of 87%, 74%, and 31% in A and 94%, 87%, and 55% in B at four months, one year, and five years respectively, p<0.001). The increased risk of death was seen principally during the first few months of dialysis. ESRF associated with systemic disease was more prevalent in A. There were small but significant differences in predialysis clinical data, including age and serum albumin (p<0.001). Fewer patients in A were suitable for transplant listing (p<0.01). In the regression analysis, age, diabetes, predialysis serum albumin, suitability for transplant work-up and listing (“transplantability”), and the interval between referral and dialysis were significant predictors of survival. In summary, this study strengthens the previously reported association between late referral of ESRF patients and subsequent poor survival on dialysis. This important message is relevant to all potential referring physicians. The high mortality rate of patients with ESRF treated by dialysis is determined principally by irreversible factors such as age and comorbidity. We have demonstrated in a single centre retrospective study of more than 1200 patients with ESRF that a short duration of specialist predialysis follow up is associated with an increased risk of death on dialysis, principally during the first few months of treatment. Delays in the referral to renal specialist services of patients with advanced chronic renal failure should be minimised.